Metoject Pen®

Metoject PEN is indicated for the treatment of:

• Active rheumatoid arthritis in adult patients,
• Severe active polyarticular juvenile idiopathic arthritis when the response to nonsteroidal anti-inflammatory drugs (NSAIDs) has been inadequate.
• Moderate to severe psoriasis in adult patients, and severe psoriatic arthritis in adults.
• Mild to moderate Crohn’s disease in adult patients when adequate treatment with other medications is not possible.

• Metoject Pen 7,5 mg/0,15 ml, 1 pre-filled pen
• Metoject Pen 10 mg/0,20 ml, 1 pre-filled pen
• Metoject Pen 10 mg/0,20 ml, 4 pre-filled pens
• Metoject Pen 12,5 mg/0,25 ml, 1 pre-filled pen
• Metoject Pen 15 mg/0,30 ml, 1 pre-filled pen
• Metoject Pen 15 mg/0,30 ml, 4 pre-filled pens
• Metoject Pen 17,5 mg/0,35 ml, 1 pre-filled pen
• Metoject Pen 17,5 mg/0,35 ml, 4 pre-filled pens
• Metoject Pen 20 mg/0,40 ml, 1 pre-filled pen
• Metoject Pen 20 mg/0,40 ml, 4 pre-filled pens
• Metoject Pen 22,5 mg/0,45 ml, 4 pre-filled pens
• Metoject Pen 25 mg/0,50 ml, 1 pre-filled pen
• Metoject Pen 25 mg/0,50 ml, 4 pre-filled pens
• Metoject Pen 27,5 mg/0,55 ml, 1 pre-filled pen
• Metoject Pen 30 mg/0,60 ml, 1 pre-filled pen